Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Notable people
Kevin Tang
Signature - Title
/s/ Kevin Tang - Manager
Location
San Diego, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TANG CAPITAL MANAGEMENT LLC.

Follow Filing Activity

Follow TANG CAPITAL MANAGEMENT LLC and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ITOS ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $101,100 -$38,586,756 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 29 Aug 2025
CRGX Cargo Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $44,700 -$13,631,846 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 19 Aug 2025
ALLK Allakos Inc. Common Stock, par value $0.001 per share 100% $3,200 -$2,778,780 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 15 May 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $60,117,785 +$12,881,057 17,176,510 +27% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.9% $63,650,358 4,941,798 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 9.9% $6,208,827 8,223,612 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 9.9% $1,296,343 3,812,773 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.6% $9,198,699 5,859,044 TANG CAPITAL MANAGEMENT, LLC 03 Mar 2025
AUPH Aurinia Pharmaceuticals Inc. Common Shares, no par value 9.2% $170,846,115 12,229,500 0% TANG CAPITAL MANAGEMENT, LLC 23 Mar 2026
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 9% 664,314 TANG CAPITAL MANAGEMENT, LLC 30 Mar 2026
PMVP PMV Pharmaceuticals, Inc. Common Stock, par value $0.00001 per share 8.9% $6,702,907 4,720,357 TANG CAPITAL MANAGEMENT, LLC 16 Sep 2025
GLPG Galapagos NV Ordinary shares, no par value 8.4% $192,587,107 +$22,486,521 5,559,674 +13% TANG CAPITAL MANAGEMENT, LLC 27 Oct 2025
DERM Journey Medical Corporation Common Stock, par value $0.0001 per share 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
CAPR Capricor Therapeutics, Inc. Common Stock, par value $0.001 per share 6.6% $98,136,074 3,399,900 TANG CAPITAL MANAGEMENT, LLC 16 Jan 2026
IMCR Immunocore Holdings plc American Depositary Shares, each representing one ordinary share, nominal value GBP 0.002 per share 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share 5.2% $46,556,874 2,178,609 TANG CAPITAL MANAGEMENT, LLC 28 Mar 2025
CBIO Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 5% $8,785,000 700,000 TANG CAPITAL MANAGEMENT, LLC 02 Oct 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 5% $1,183,700 -$1,112,990 3,115,000 -48% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 4.8% $1,325,990 -$199,028 3,399,975 -13% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 3.5% $355,790 -$531,990 66,879 -60% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
OTLK Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share 3.4% $3,030,000 -$808,000 1,500,000 -21% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.8% $89,776,771 -$95,634,047 1,188,624 -52% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 2.4% $62,064,160 -$42,895,840 1,892,200 -41% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share 2.1% $2,739,523 -$10,236,562 1,480,823 -79% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
EOLS Evolus, Inc. Common Stock, par value $0.00001 per share 1.9% $7,038,160 -$21,197,145 1,245,692 -75% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 0.1% $51,050 6,158 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share 0% $0 -$821,300 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 0% $0 -$5,779,625 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
DTIL Precision BioSciences, Inc. Common Stock, par value $0.000005 per share 0% $0 -$2,767,395 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
HELP Cybin Inc. Common Stock, no par value 0% $0 -$14,146,650 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
KROS Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$47,170,188 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 0% $0 -$47,582,347 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
HLVX HilleVax, Inc. Common Stock, par value $0.0001 per share 0% $0 -$10,135,200 0 -100% TANG CAPITAL MANAGEMENT, LLC 17 Sep 2025
SLRN Acelyrin, Inc. Common Stock, par value $0.00001 per share 0% $0 -$21,620,498 0 -100% TANG CAPITAL MANAGEMENT, LLC 21 May 2025
MNPR Monopar Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024

Schedules 13D/G Reported by TANG CAPITAL MANAGEMENT LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored